Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men

Nutrition and Cancer

Volumn 36, Issue 1, 2000, Pages 19-26

  Persson Moschos, Marie E K ^a   Stavenow, Lars ^b   Åkesson, Björn ^a   Lindgärde, Folke ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SELENOPROTEIN; SELENOPROTEIN P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIET SUPPLEMENTATION; GASTROINTESTINAL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROTEIN DETERMINATION; RESPIRATORY TRACT CANCER; SELENIUM DEFICIENCY; SWEDEN;

EID: 0034029164     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3601_4     Document Type: Article

References (61)

1. Comstock, GW, Bush, TL, and Helzlsouer, K: Serum retinol, β-carotene, vitamin E and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135, 115-121, 1992.
2. Doll, R: An overview of the epidemiological evidence linking diet and cancer. Proc Nutr Soc 49, 119-131, 1989.
3. Spallholz, JE: Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 10, 260-270, 1997.
4. Ip, C: Selenium and experimental cancer. Ann Clin Res 18, 22-29, 1986.
5. Blot, WJ, Li, J-Y, Taylor, PR, Guo, W, Dawsey, SM, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. JNCI 15, 1483-1492, 1993.
6. Clark, LC, Combs, GF, Turnbull BW, Slate, EH, Chalker, DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 276, 1957-1963, 1996.
7. Gladyshev, VN, Jeang, K-T, Wootton, JC, and Hatfield, DL: A new human selenium-containing protein. Purification, characterization and cDNA sequence. J Biol Chem 273, 8910-8915, 1998.
8. Behne, D, Kyriakopoulos, A, Kalklösch, M, Weiss-Nowak, C, Pfeifer, H, et al.: Two new selenoproteins found in the prostatic glandular epithelium and in the spermatid nuclei. Biomed Environ Sci 10, 340-345, 1997.
9. Tamura, T, and Stadtman, T: A new selenoprotein from human lung adenocarcinoma cells: purification, properties and thioredoxin reductase activity. Proc Natl Acad Sci USA 93, 1006-1011, 1996.
10. Burk, RF, Early, DS, Hill, KE, Palmer, IS, and Boeglin, ME: Plasma selenium in patients with cirrhosis. Hepatology 27, 794-798, 1998.
11. Persson-Moschos, M: Selenoprotein P in Human Plasma. Immunoassay of a New Biochemical Marker of Selenium Status (Licenciate thesis). Lund: University of Lund, 1996.
12. Burk, RF, and Hill, KE: Selenoprotein P: a selenium-rich extracellular glycoprotein. J Nutr 124, 1891-1897, 1994.
13. Burk, RF, Hill, KE, Awad, JA, Morrow, JD, Kato, T, et al.: Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and Selenoprotein P. Hepatology 21, 561-569, 1995.
14. Arteel, GE, Mostert, V, Oubrahim, H, Briviba, K, Abel, J, et al.: Protection by Selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol Chem 379, 1201-1205, 1998.
15. Burk, RF, Hill, KE, Boeglin, ME, Ebner, FF, and Chittum, HS: Selenoprotein P associates with endothelial cells in rat tissues. Histochem Cell Biol 108, 11-15, 1997.
16. Persson-Moschos, M, Huang, W, Srikumar, TS, Lindeberg, S, and Akesson, B: Selenoprotein P in serum as a biochemical marker of selenium status. Analyst 120, 833-836, 1995.
17. Petersson, B, Trell E, Henningsen, N-C, and Hood, B: Risk factors for premature death in middle aged men. Br Med J 288, 1264-1267, 1984.
18. Mantel, N: Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58, 690-700, 1963.
19. Fex, G, Pettersson, B, and Åkesson, B: Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr Cancer 10, 221-229, 1987.
20. Knekt, P, Aromaa, A, Maatela, J, Alfthan, G, Aaran R-K, et al.: Serum selenium and subsequent risk of cancer among Finnish men and women. JNCI 82, 864-868, 1990.
21. Knekt, PO, Aromaa, A, Maatela, J, Alfthan, G, Aaran, R-K, et al.: Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer 42, 846-850, 1988.
22. Salonen, JT, Salonen, R, Lappeteläinen, R, Mäenpää, PH, Alfthan, G, et al.: Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 290, 417-420, 1985.
23. Salonen, JT, Alfthan, G, Huttunen, JK, and Puska, P: Association between serum selenium and the risk of cancer. Am J Epidemiol 120, 342-349, 1984.
24. Willet, WC, Polk, BF, Morris, JS, Stampfer, MJ, Pressel, S, et al.: Pre-diagnostic serum selenium and risk of cancer. Lancet 2, 130-134, 1983.
25. Comstock, WC, Alberg, AJ, Huang, H-Y, Burke, AE, Hoffman, SC, et al.: The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 6, 907-916, 1997.
26. Kabuto, M, Imai, H, Yonezawa, C, Neriishi, K, Akiba, S, et al.: Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomarkers Prev 3, 465-469, 1994.
27. Coates, Ri, Weiss, NS, Daling, JR, Morris, JS, and Labbe, RF: Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128, 515-523, 1988.
28. Ringstad, J, Jacobsen, BK, Stretli, S, and Thomassen, Y: Serum selenium concentration associated with risk of cancer. J Clin Pathol 41, 454-457, 1988.
29. Nomura, A, Heilburn, L, Morris, JS, and Stemmermann, GN: Serum selenium and the risk of cancer by specific sites: case-control analysis of prospective data. JNCI 79, 103-108, 1987.
30. Knekt, P: Epidemiological evidence on natural antioxidants and lung cancer. 2nd Int Conf on Natural Antioxidants and Anticarcinogens in Nutrition, Health and Disease, Helsinki, Finland, June 1998
31. Virtamo, J, Valkeila, E, Alfthan, G, Punsar, S, Huttunen, J, et al.: Serum selenium and risk of cancer. Cancer 60, 145-148, 1987.
32. Chen, J, Geissler, C, Parpia, B, Li, J, and Campbell, C: Antioxidant status and cancer mortality in China. Int J Epidemiol 21, 625-635, 1992.
33. van den Brandt, PA, Goldbohm, RA, van't Veer, P, Bode, P, Dorant, E, et al.: A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 15, 4860-4865, 1993.
34. van den Brandt, PA, Goldbohm, RA, van't Veer, P, Bode, P, Dorant, E, et al.: A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. JNCI 85, 224-229, 1993.
35. Clark, LC, Cantor, KP, and Allaway, WH: Selenium in forage crops and cancer mortality in US counties. Arch Environ Health 46, 37-42, 1991.
36. Shamberger, RJ, Tytko, SA, and Willis, CE: Antioxidants and cancer. VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health 31, 231-235, 1976.
37. Swanson, CA, Longnecker, MP, Veillon, C, Howe, SM, Levander, OA, et al.: Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am J Clin Nutr 52, 858-862, 1990.
38. Hagmar, L, Persson-Moschos, M, Åkesson, B, and Schütz, A: Plasma levels of selenium, setenoprotein P and glutathione peroxidase and their correlations to fish intake and serum levels of thyrotropin and thyroid hormones: a study on Latvian fish consumers. Eur J Clin Nutr 52, 796-800, 1998.
39. Persson-Moschos, M, Alfthan, G, and Akesson, B: Plasma seleno-protein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 52, 363-367, 1998.
40. Hill, KE, Xia, Y, Åkesson, B, Boeglin, ME, and Burk, RF: Seleno-protein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 126, 138-145, 1996.
41. Rannem, T, Persson-Moschos, M, Huang, W, Staun, M, and Åkesson, B: Selenoprotein P in patients on home parenteral nutrition. J Parent Enterol Nutr 20, 287-291, 1996.
42. Marchaluk, E, Persson-Moschos, M, Thorling, EB, and Akesson, B: Variation in selenoprotein P concentration in serum from different European regions. Eur J Clin Nutr 49, 42-48, 1995.
43. Levander, OA, Alfthan, G, Arvilommi, H, Gref, CG, Huttunen, JK., et al.: Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr 37, 887-897, 1983.
44. Åkesson, B, Huang, W, Persson-Moschos, M, Marchaluk, E, Jacobsson, L, et al.: Glutathione peroxidase, selenoprotein P and selenium in serum of elderly subjects in relation to other biomarkers of nutritional status and food intake. J Nutr Biochem 8, 508-517, 1997.
45. Becker, W: Befolkningens kostvanor och näringsintag i Sverige 1989. Uppsala: Statens Livsmedelsverk, 1994.
46. Callmer, E, Riboli, E, Saracci, R, Akesson, B, and Lindgärde, F: Dietary assessment methods evaluated in the Malmö Food Study. J Intern Med 233, 53-57, 1993.
47. Zachara, BA, Marchaluk-Wisniewska, E, Maciag, A, Peplinski, J, Skokowski, J, et al.: Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 175, 321-332, 1997.
48. Lloyd, B, Lloyd, RS, and Clayton, BE: Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J Epidemiol Commun Health 37, 213-217, 1983.
49. Virtanen, SM, van't Veer, P, Kok, F, Kardinaal, AFM, and Aro, A: Predictors of adipose tissue tocopherol and toenail selenium levels in nine countries: the EURAMIC study. Eur J Clin Nutr 50, 599-606, 1996.
50. Dreher, I, Jacobs, T, and Köhrle, J: Cloning and characterization of the human selenoprotein P promoter. J Biol Chem 272, 29364-29371, 1997.
51. Halliwell, B: Antioxidants and human disease: a general introduction: Nutr Rev 55, S44-S52, 1997.
52. Sies, H, Sharov, V, Klotz, L-O, and Briviba, K.: Glutathione peroxidase protects against peroxynitrite-mediated oxidations. J Biol Chem 272, 27812-27817, 1997.
53. Ellingsen, DG, Thomassen, Y, Aaseth, J, and Alexander, J: Cadmium and selenium in blood and urine related to smoking habits and previous exposure to mercury vapor. J Appl Toxicol 17, 337-343, 1997.
54. Osman, K, Schutz, A, Åkesson, B, Maciag, A, and Vahter, M: Interactions between essential and toxic elements in lead-exposed children in Katowice, Poland. Clin Biochem 31, 657-665, 1998.
55. Dalongeville, J, Marécaux, N, Fruchart, J-C, and Amouye, P: Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 128, 1450-1457, 1998.
56. Redman, C, Xu, MJ, Peng, Y-M, Scott, JA, Payne, C, et al.: Involvement of polyamines in selenomethionine-induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 18, 1195-1202, 1997.
57. 2 toxicity. Carcinogenesis 16, 1579-1584, 1995.
58. Ip, C, and Lisk, DJ: Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutr Cancer 28, 184-188, 1997.
59. Harrisson, PR, Lanfear, J, Wu, L, Fleming, J, McGarry, L, et al.: Chemopreventive and growth inhibitory effects of selenium. Biomed Environ Sci 10, 235-245, 1997.
60. Anneren, G, Magnusson, CG, and Nordvall, SL: Increase in serum concentrations of IgG2 and IgG4 by selenium supplementation in children with Down's syndrome. Arch Dis Child 65, 1353-1355, 1990.
61. McKenzie, RC, Rafferty, TS, and Beckett, GJ: Selenium: an essential element for immune function. Immunol Today 19, 342-345, 1998.